Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


XBiotech Inc. (XBIT) shares are rising on Thursday morning trade as the biopharmaceutical company reported that its COVID-19 candidate True Human antibody therapy may also be used for treating the COVID-19 mutant virus that recently emerged in the UK and is now rapidly spreading across the US.


RTTNews | Jan 21, 2021 09:56AM EST

09:55 Thursday, January 21, 2021 (RTTNews.com) - XBiotech Inc. (XBIT) shares are rising on Thursday morning trade as the biopharmaceutical company reported that its COVID-19 candidate True Human antibody therapy may also be used for treating the COVID-19 mutant virus that recently emerged in the UK and is now rapidly spreading across the US.

Currently, shares are at $17.23, up 6 percent from the previous close of $16.37 on a volume of 308,815. For the 52-week period, the shares have traded in a range of $8.72 to $23.87 on average volume of 88,179.

Read the original article on RTTNews ( https://www.rttnews.com/3162291/stock-alert-xbiotech-up-6.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC